FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3215445104> ?p ?o ?g. }

• W3215445104 abstract "Long-acting somatostatin analogues (SSAs) are the most commonly used drugs in the management of neuroendocrine tumours (NETs) because of their ability to control symptoms and prolong survival. SSA use is associated with changes in glucose metabolism. However, the impacts on glycaemic control and body mass index (BMI) caused by SSAs in NETs are largely unknown. In the present study, we evaluated the effects of SSA treatment on BMI and glycated haemoglobin (HbA1c) in our cohort of patients with NETs. We also assessed changes in glycaemic control and BMI before and after SSA treatment. In addition, we assessed the incidence of new diabetes or whether there was worsening of glycaemic control for patients with pre-existing diabetes. The study comprised a retrospective study of 279 patients with NETs who were treated with SSAs between January 2014 and January 2019. Glycaemic control was assessed by measuring changes in Hba1c. A number needed to harm analysis was used to look at new cases of diabetes within the study population. Treatment with SSAs was associated with a mean increase in HbA1c of 3.35 ± 6.30 mmol mol-1 despite a mean decrease in BMI of -1.04 ± 2.79 kg m-2 . There were 19 new cases of type 2 diabetes mellitus (T2DM) in the population of 209 with a number needed to harm of 12.5. Of the 34 patients with pre-existing T2DM, five had worsening of their mean HbA1c. Treatment with SSAs for NETs is associated with an increase in HbA1c, despite a reduction in BMI and, importantly, a risk of developing T2DM with a number needed to harm of 12.5. This project was registered with the National Health Service Clinical Audit and Registries. It has a CARMS number - 17666." @default.
• W3215445104 created "2021-12-06" @default.
• W3215445104 creator A5022719000 @default.
• W3215445104 creator A5032033080 @default.
• W3215445104 creator A5035078852 @default.
• W3215445104 creator A5035268946 @default.
• W3215445104 creator A5035483877 @default.
• W3215445104 creator A5052716490 @default.
• W3215445104 creator A5060246000 @default.
• W3215445104 creator A5070033060 @default.
• W3215445104 creator A5079049078 @default.
• W3215445104 creator A5079297632 @default.
• W3215445104 creator A5083863258 @default.
• W3215445104 creator A5091795929 @default.
• W3215445104 date "2022-01-25" @default.
• W3215445104 modified "2023-10-06" @default.
• W3215445104 title "The effects of somatostatin analogues on glycaemia in the treatment of neuroendocrine tumours" @default.
• W3215445104 cites W1969709966 @default.
• W3215445104 cites W1971816555 @default.
• W3215445104 cites W1996943463 @default.
• W3215445104 cites W2000637330 @default.
• W3215445104 cites W2007799350 @default.
• W3215445104 cites W2020184553 @default.
• W3215445104 cites W2024255334 @default.
• W3215445104 cites W2025301846 @default.
• W3215445104 cites W2029084853 @default.
• W3215445104 cites W2053551132 @default.
• W3215445104 cites W2056529559 @default.
• W3215445104 cites W2061497198 @default.
• W3215445104 cites W2071851324 @default.
• W3215445104 cites W2075204862 @default.
• W3215445104 cites W2075577428 @default.
• W3215445104 cites W2080448046 @default.
• W3215445104 cites W2081654497 @default.
• W3215445104 cites W2085863714 @default.
• W3215445104 cites W2091205538 @default.
• W3215445104 cites W2101992531 @default.
• W3215445104 cites W2123997600 @default.
• W3215445104 cites W2131853244 @default.
• W3215445104 cites W2133418708 @default.
• W3215445104 cites W2135049144 @default.
• W3215445104 cites W2137142564 @default.
• W3215445104 cites W2156142359 @default.
• W3215445104 cites W2157320989 @default.
• W3215445104 cites W2160683325 @default.
• W3215445104 cites W2177793853 @default.
• W3215445104 cites W2531851839 @default.
• W3215445104 cites W2785648231 @default.
• W3215445104 cites W2792093082 @default.
• W3215445104 cites W2796978679 @default.
• W3215445104 cites W2802284014 @default.
• W3215445104 cites W2952436116 @default.
• W3215445104 cites W3009711324 @default.
• W3215445104 cites W3087857007 @default.
• W3215445104 cites W3128472330 @default.
• W3215445104 doi "https://doi.org/10.1111/jne.13064" @default.
• W3215445104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35078270" @default.
• W3215445104 hasPublicationYear "2022" @default.
• W3215445104 type Work @default.
• W3215445104 sameAs 3215445104 @default.
• W3215445104 citedByCount "2" @default.
• W3215445104 countsByYear W32154451042023 @default.
• W3215445104 crossrefType "journal-article" @default.
• W3215445104 hasAuthorship W3215445104A5022719000 @default.
• W3215445104 hasAuthorship W3215445104A5032033080 @default.
• W3215445104 hasAuthorship W3215445104A5035078852 @default.
• W3215445104 hasAuthorship W3215445104A5035268946 @default.
• W3215445104 hasAuthorship W3215445104A5035483877 @default.
• W3215445104 hasAuthorship W3215445104A5052716490 @default.
• W3215445104 hasAuthorship W3215445104A5060246000 @default.
• W3215445104 hasAuthorship W3215445104A5070033060 @default.
• W3215445104 hasAuthorship W3215445104A5079049078 @default.
• W3215445104 hasAuthorship W3215445104A5079297632 @default.
• W3215445104 hasAuthorship W3215445104A5083863258 @default.
• W3215445104 hasAuthorship W3215445104A5091795929 @default.
• W3215445104 hasConcept C120665830 @default.
• W3215445104 hasConcept C121332964 @default.
• W3215445104 hasConcept C126322002 @default.
• W3215445104 hasConcept C134018914 @default.
• W3215445104 hasConcept C2776297358 @default.
• W3215445104 hasConcept C2777180221 @default.
• W3215445104 hasConcept C2780221984 @default.
• W3215445104 hasConcept C2908647359 @default.
• W3215445104 hasConcept C555293320 @default.
• W3215445104 hasConcept C61511704 @default.
• W3215445104 hasConcept C70818257 @default.
• W3215445104 hasConcept C71924100 @default.
• W3215445104 hasConcept C72563966 @default.
• W3215445104 hasConcept C99454951 @default.
• W3215445104 hasConceptScore W3215445104C120665830 @default.
• W3215445104 hasConceptScore W3215445104C121332964 @default.
• W3215445104 hasConceptScore W3215445104C126322002 @default.
• W3215445104 hasConceptScore W3215445104C134018914 @default.
• W3215445104 hasConceptScore W3215445104C2776297358 @default.
• W3215445104 hasConceptScore W3215445104C2777180221 @default.
• W3215445104 hasConceptScore W3215445104C2780221984 @default.
• W3215445104 hasConceptScore W3215445104C2908647359 @default.
• W3215445104 hasConceptScore W3215445104C555293320 @default.
• W3215445104 hasConceptScore W3215445104C61511704 @default.
• W3215445104 hasConceptScore W3215445104C70818257 @default.

• next